While Comp-10 inhibits IMPDH2 activity, disrupts R/R formation, and prevents tumor cell proliferation, its effects on the immune system, particularly on anti-tumor immune responses, are not yet fully understood. The gene discussed is IMPDH2; the disease is neoplasm.